核苷二磷酸激酶C抑制人类心力衰竭中的环磷酸腺苷生成
研究探讨NDPK-C在心脏cAMP生成和收缩功能中的作用。发现NDPK-C是NDPK-B/G蛋白复合物形成的必需因子,在终末期人类心衰、大鼠长期异丙肾上腺素刺激及大鼠新生心肌细胞异丙肾上腺素孵育后表达上调;过表达增加cAMP并增敏收缩反应,敲低则降低cAMP;斑马鱼胚胎敲低导致心脏水肿和心室功能障碍;NDPK-B敲除小鼠长期异丙肾上腺素刺激下出现收缩功能障碍和加重的心脏重构;人类终末期心衰中NDPK-C/Gαi2复合物增加而NDPK-C/Gαs相互作用减少,可能通过Gαs向Gαi2转换导致cAMP降低。
要点
- NDPK-C是NDPK-B/G蛋白复合物形成的必需因子
- NDPK-C在终末期人类心衰及异丙肾上腺素刺激后表达上调
- NDPK-C过表达增加cAMP并增敏收缩,敲低降低cAMP
核心结论
- NDPK-C是NDPK亚型间及NDPK亚型与G蛋白相互作用的关键必需因子,是β-肾上腺素能受体/cAMP信号和心脏收缩力的新型关键调节因子;通过从Gαs向Gαi2转换,NDPK-C可能促进心衰中cAMP降低及相关收缩功能障碍。
研究设计与样本
- 采用实时聚合酶链反应、(远)蛋白质印迹、免疫沉淀和免疫细胞化学研究NDPKs的表达、与G蛋白的相互作用及定位;用免疫测定或荧光共振能量转移测定cAMP水平;在心肌细胞(细胞缩短)和体内(缩短分数)测定收缩力。
主要发现
- NDPK-C是NDPK-B/G蛋白复合物形成的必需因子。
- NDPK-C的蛋白和mRNA水平在终末期人类心衰、大鼠经渗透微泵长期异丙肾上腺素刺激后以及大鼠新生心肌细胞与异丙肾上腺素孵育后上调。
- 异丙肾上腺素还促进NDPK-C向质膜转位。
- 心肌细胞中过表达NDPK-C增加cAMP水平并使心肌细胞对异丙肾上腺素诱导的收缩力增强更敏感,而敲低NDPK-C降低cAMP水平。
- 体内斑马鱼胚胎中敲低NDPK-C导致心脏水肿和心室功能障碍;NDPK-B敲除小鼠NDPK-C表达未改变,但长期异丙肾上腺素刺激下出现收缩功能障碍和加重的心脏重构;人类终末期心衰中NDPK-C与Gαi2复合物形成增加而NDPK-C/Gαs相互作用减少。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic heart failure (HF) is associated with altered signal transduction via β-adrenoceptors and G proteins and with reduced cAMP formation. Nucleoside diphosphate kinases (NDPKs) are enriched at the plasma membrane of patients with end-stage HF, but the functional consequences of this are largely unknown, particularly for NDPK-C. Here, we investigated the potential role of NDPK-C in cardiac cAMP formation and contractility. METHODS: Real-time polymerase chain reaction, (far) Western blot, immunoprecipitation, and immunocytochemistry were used to study the expression, interaction with G proteins, and localization of NDPKs. cAMP levels were determined with immunoassays or fluorescent resonance energy transfer, and contractility was determined in cardiomyocytes (cell shortening) and in vivo (fractional shortening). RESULTS: NDPK-C was essential for the formation of an NDPK-B/G protein complex. Protein and mRNA levels of NDPK-C were upregulated in end-stage human HF, in rats after long-term isoprenaline stimulation through osmotic minipumps, and after incubation of rat neonatal cardiomyocytes with isoprenaline. Isoprenaline also promoted translocation of NDPK-C to the plasma membrane. Overexpression of NDPK-C in cardiomyocytes increased cAMP levels and sensitized cardiomyocytes to isoprenaline-induced augmentation of contractility, whereas NDPK-C knockdown decreased cAMP levels. In vivo, depletion of NDPK-C in zebrafish embryos caused cardiac edema and ventricular dysfunction. NDPK-B knockout mice had unaltered NDPK-C expression but showed contractile dysfunction and exacerbated cardiac remodeling during long-term isoprenaline stimulation. In human end-stage HF, the complex formation between NDPK-C and Gαi2 was increased whereas the NDPK-C/Gαs interaction was decreased, producing a switch that may contribute to an NDPK-C-dependent cAMP reduction in HF. CONCLUSIONS: Our findings identify NDPK-C as an essential requirement for both the interaction between NDPK isoforms and between NDPK isoforms and G proteins. NDPK-C is a novel critical regulator of β-adrenoceptor/cAMP signaling and cardiac contractility. By switching from Gαs to Gαi2 activation, NDPK-C may contribute to lower cAMP levels and the related contractile dysfunction in HF.
引用
- Abu-Taha IH, Heijman J, Hippe HJ, et al. Nucleoside Diphosphate Kinase-C Suppresses cAMP Formation in Human Heart Failure. Circulation. 2016. PMID: 27927712. doi:10.1161/CIRCULATIONAHA.116.022852
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。